Low Doses of Lithium Could be Alzheimer’s Kryptonite

Less may be more when it comes to fighting Alzheimer’s disease with lithium.

Lithium therapy to treat Alzheimer’s disease is far from a new concept, but the variation in studies has prevented definitive progress. Additionally, multiple treatments of high doses of lithium cause serious side effects, rendering the approach impractical for extended treatments, especially in older people most affected by the disease. However, a recent Science Tech Daily article suggests lower doses of lithium may be the key to halting the progression of Alzheimer’s disease.

Fresh from the show floor: pharma packaging innovations for 2026
Serialization mandates. Containment demands. Sterile barrier requirements. Our editors found the pharma packaging innovations addressing your biggest challenges at PACK EXPO Las Vegas. Get your free curated report now.
GET YOUR COPY
Fresh from the show floor: pharma packaging innovations for 2026